BioIntelligence Technologies inc.

06/17/2021

Vous avez vu plusieurs bonnes nouvelles à notre sujet? Nous avons besoin de renfort!
Nous embauchons: Adjoint / Adjointe de direction.
Vous êtes intéressé ou connaissez quelqu'un qui serait intéressé?
https://biointelligence.com/fr/carriere/adjoint-adjointe-de-direction/

03/22/2021

FR
Une technologie développée initialement à la Faculté de Génie de l'Université de Sherbrooke et adaptée par notre équipe fait son entrée dans le domaine pharmaceutique. Cette technologie non destructive et non invasive mesure en temps réel l'évolution des procédés biotechnologiques permettant ainsi de diminuer les pertes en favorisant les prises de décision précoce dans la régulation des procédé.
EN
A technology initially developed at the Faculty of Engineering of Université de Sherbrooke and adapted by our team is entering the pharmaceutical industry. This non-destructive and non-invasive technology measures in real-time the evolution of biotechnological processes, thus making it possible to reduce losses by enabling early decision-making in process regulation.

BioIntelligence Technologies aurait trouvé une façon de limiter les pertes dans la production de vaccins.

03/01/2021

EN
This is an opportunity to do our part to fight the pandemic. Our high-precision measuring instrument is quietly making its way into the pharmaceutical industry to produce the COVID-19 vaccine.
------------------------------------------------------------------------
FR
C’est l’occasion de faire notre part pour lutter contre la pandémie. Notre instrument de mesure d’haute précision fait tranquillement sa place dans le domaine de la pharmaceutique afin de produire le vaccin contre la COVID-19.

L’expertise de BioIntelligence Technologies sera notamment mise à profit au Centre de production de produits biologiques du Conseil national de recherches du Canada (CNRC), actuellement en construction sur l’avenue Royalmount, à Montr

02/02/2021

Presentation in French

Aujourd'hui, notre CEO fait parti du panel qui discutera du rôle des incubateurs et des accélérateurs d'entreprises qui aide les entrepreneurs.

Encore une fois, vous étiez près de 150 à prendre part à notre rendez-vous matinal! On se retrouve demain pour la matinée thématique Continuum d’accompagnement...

01/18/2021

This February 2 and 3, 2021, our CEO, Joël Sirois will be part of the panel on "Data & Artificial intelligence" for bioprocesses at theTWB annual conference. The event is 100% virtual which will allow you to attend it wherever you are in the world.

“Data & Artificial Intelligence” Session
Joel Sirois, Founder-President & CEO from BioInTech
3 February, 2021 | 2:30 to 3:30 pm CET
Registration : https://lnkd.in/d6h_cXs

01/12/2021

Reusing the residues produced during the making of Whisky is the challenge that IBioIC and SWRI have set themselves. It is a sustainable project that reduces both the volume of waste and the extraction of natural resources. The use of biotechnology allows the production of higher value-added products from biomass that was originally destined to be thrown away. The accessibility to new technologies allows biotechnology to expand and offer more sustainable alternatives to meet today's challenges. Which technologies allow you to go further?

An exciting new project has launched that brings together Scotland’s most successful export industry and leading biotechnology innovators to find new sustainable solutions from whisky co-products.

01/06/2021

The human body works with thousands of perfectly chained biochemical reactions that maintain life. More and more research is being done to understand these mechanisms. Researchers at the Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer Polytechnic Institute have highlighted the correlation between decreased enzyme activity and increased fracture risk. A better understanding of this type of phenomenon opens the door to possible solutions. Very often the production of such medical products will require rigorous monitoring supported by adapted technologies.

A new study suggests that a loss of enzymatic processes within the body can increase a person’s risk of bone fracture.

01/05/2021

It is difficult to make an assessment of the year 2020 without mentioning the great rise of biotechnologies. This field offers concrete solutions to today's problems. Whether it is the restoration of natural environments affected by pollution, the production of vaccines, or the proposal of sustainable food alternatives, biotechnologies are everywhere and contribute to a better future. We look forward to discovering what 2021 has in store for us and seeing the progression of new technologies.



https://www.forbes.com/sites/brucebooth/2021/01/04/the-biotech-paradox-of-2020-a-year-in-review/?sh=5c4db6ed43b3&fbclid=IwAR3gR9Xw5zNbLGSyzviCCxUSa59pgobVOqWCUgRIVj9F_40gf0CjIK2hlCo

2020 was an incredibly paradoxical year for those of us in biotech: the striking dichotomy of simultaneously experiencing agonizing tragedy alongside buoyant optimism.

12/29/2020

A date to add to your calendar :
February 2 and 3, 2021, our CEO, Joël Sirois will be part of the panel on "Data & Artificial intelligence" for bioprocesses at the Toulouse White Biotechnology (TWB) annual conference. The event is 100% virtual which will allow you to attend it wherever you are in the world.

https://www.linkedin.com/feed/update/urn:li:activity:6749690478612115456

12/08/2020

The biological reactions that enable the production of your products are very complex and sensitive to variations. Once it is possible to capture all this information, you must be able to interpret it in order to make the right decisions at the right time to maximize production. Moreover, the ability to detect variations early saves precious time, which helps to reduce batch losses. There are different strategies such as the use of artificial intelligence. What would be the most suitable method of capture and interpretation for your bioprocess?

https://www.genengnews.com/topics/bioprocessing/context-vital-to-making-most-of-bioprocess-data/

Robust IT infrastructure is critical for biopharmaceutical companies going digital.